BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2010
View Archived Issues
Updates on ADX-10059 for clinical management of GERD
Read More
TOL-101 antibody modulates T-cell responses in vitro and in vivo
Read More
Diannexin reduces ischemia/reperfusion injury in renal transplant recipients
Read More
Zydus-Cadila claims new thyroid hormone receptor beta ligands
Read More
Alimentary Health presents new immunomodulatory agents
Read More
Novel Pot1 inhibitors claimed by French researchers
Read More
Metabolex describes new GPR120 agonists for type 2 diabetes
Read More
CNRS researchers describe novel antibacterial agents
Read More
GSK's high-throughput screen reveals potent antimalarial leads
Read More
Dofetilide shows clinical potential for treatment of persistent AF
Read More
Lytix obtains Swedish approval for Lytixar phase I/IIa trial in nasal MRSA infection
Read More
Revotar reports phase IIa data on bimosiamose in COPD
Read More
InVasc Therapeutics receives two phase I SBIR grants
Read More
Hawthorn acquires license to anticancer antibodies from University of Pittsburgh
Read More
Ad5.SSTR/TK.RGD/ganciclovir active in phase I trial in gynecologic cancer
Read More
Pharming initiates divestment of DNage in refocusing effort
Read More
Galapagos initiates clinical studies of GLPG-0492 for cachexia
Read More
Evotec and Boehringer Ingelheim pain collaboration advances into the clinic
Read More
Discovery Labs completes revalidation required for potential approval of Surfaxin in RDS
Read More
NexMed to meet with FDA on phase II/III alprostadil trial protocol in Raynaud's syndrome
Read More
GAP-107B8 active against ovarian cancer
Read More
NORD recognizes Acorda's efforts in multiple sclerosis research
Read More
CYT003-QbG10 demonstrates efficacy in allergic asthma
Read More
Ablynx and Pfizer extend anti-TNF-alpha Nanobody research collaboration
Read More
Vaxon's Vx-001 to advance from phase I/II to phase III in NSCLC
Read More
Labopharm and Angelini group complete joint venture for U.S. Oleptro launch
Read More
Victory and MiddleBrook Pharma sign asset purchase agreement
Read More